Search

A fundamental change in the way hypertension is measured, and studies to identify evidence-based blood pressure goals have been highlighted as top priorities by one of Sweden’s prominent hyperte

The illusive angiotensin AT2 receptor could become an important new target for therapy in the overall care of patients with hypertension. A leading researcher in cardiovascular medical science has fou

Eight human genes have been recognised as modulating blood pressure by a team from London, UK, presenting findings at the European Society of Hypertension’s annual conference. The researchers ho

The global health initiatives set up in the last decade to fight killer diseases like AIDS, TB and Malaria are not investing enough in efforts made locally in countries around the world to deliver hea

Peter Nilsson explains to Peter Goodwin his clear recommendation that doctors should manage hyperglycaemia aggressively in patients with Type II diabetes following his discussions in Milan about the m

A leading scientist from Prague has announced results showing a forty per cent reduction in cardiovascular mortality overall and a sixty per cent fall in stroke deaths between 1985 and 2007 in the Cze

Hermann Haller tells Peter Goodwin about the significant health risks—including for renal disease, myocardial infarction and stroke—which are going undetected across Europe because doctors are not tes

New York cardiologist Franz Messerli explains to Peter Goodwin why he doesn’t prescribe the popular diuretic hydrochlorothiazide as initial therapy for hypertension any more, as he announced in

Josep Redon tells Peter Goodwin about a J-shaped relationship between lowering blood pressure and mortality uncovered by the ONTARGET study in patients with diabetes. LISTEN [audio:https://www.audiome

The poorest members of the global community—not necessarily geographically defined—are those who need to be targeted in healthcare development rather than countries labelled as “developing&#8221

The preparations being made for a possible pandemic of the new H1N1 influenza were explained recently in London by the Secretary General’s Representative, Dr David Nabarro, during the inaugural

Peter Goodwin interviews experts on gastrointestinal cancers at the 2009 Annual Meeting of the American Society of Clinical Oncology in Orlando, Florida